SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-020749
Filing Date
2019-04-23
Accepted
2019-04-23 17:20:15
Documents
65
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F tv518650_20f.htm 20-F 1445062
2 EXHIBIT 10.21 tv518650_ex10-21.htm EX-10.21 22207
3 EXHIBIT 23.1 tv518650_ex23-1.htm EX-23.1 3432
4 EXHIBIT 31.1 tv518650_ex31-1.htm EX-31.1 9581
5 EXHIBIT 31.2 tv518650_ex31-2.htm EX-31.2 9461
6 EXHIBIT 32.1 tv518650_ex32-1.htm EX-32.1 4639
7 EXHIBIT 32.2 tv518650_ex32-2.htm EX-32.2 4659
14 GRAPHIC tv518650_img01.jpg GRAPHIC 37533
15 GRAPHIC tv518650_img02.jpg GRAPHIC 65048
  Complete submission text file 0001144204-19-020749.txt   7189669

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT aktx-20181231.xml EX-101.INS 1920032
9 XBRL TAXONOMY EXTENSION SCHEMA aktx-20181231.xsd EX-101.SCH 33690
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aktx-20181231_cal.xml EX-101.CAL 33609
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aktx-20181231_def.xml EX-101.DEF 250536
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE aktx-20181231_lab.xml EX-101.LAB 285805
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aktx-20181231_pre.xml EX-101.PRE 297217
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 20-F | Act: 34 | File No.: 001-36288 | Film No.: 19762193
SIC: 2834 Pharmaceutical Preparations